These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8971852)

  • 21. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
    Shinotoh H; Snow BJ; Chu NS; Huang CC; Lu CS; Lee C; Takahashi H; Calne DB
    Neurology; 1997 Apr; 48(4):1053-6. PubMed ID: 9109899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of 11C-labeled L-DOPA and L-fluorodopa as positron emission tomography tracers for the presynaptic dopaminergic system.
    Torstenson R; Tedroff J; Hartvig P; Fasth KJ; Långström B
    J Cereb Blood Flow Metab; 1999 Oct; 19(10):1142-9. PubMed ID: 10532639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies.
    Saba W; Peyronneau MA; Dollé F; Goutal S; Bottlaender M; Valette H
    Nucl Med Biol; 2012 Feb; 39(2):227-33. PubMed ID: 22033025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.
    Danielsen EH; Smith DF; Gee AD; Venkatachalam TK; Hansen SB; Hermansen F; Gjedde A; Cumming P
    Synapse; 1999 Sep; 33(4):247-58. PubMed ID: 10421705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic dysfunction in midbrain dystonia: anatomoclinical study using 3-dimensional magnetic resonance imaging and fluorodopa F 18 positron emission tomography.
    Vidailhet M; Dupel C; Lehéricy S; Remy P; Dormont D; Serdaru M; Jedynak P; Veber H; Samson Y; Marsault C; Agid Y
    Arch Neurol; 1999 Aug; 56(8):982-9. PubMed ID: 10448804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
    Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
    Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positron emission tomography with 4-[18F]fluoro-L-m-tyrosine in MPTP-induced hemiparkinsonian monkeys.
    Hayase N; Tomiyoshi K; Watanabe K; Horikoshi S; Shibasaki T; Ohye C
    Ann Nucl Med; 1995 Aug; 9(3):119-23. PubMed ID: 8534583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed L-phenylalanine infusion allows for simultaneous kinetic analysis and improved evaluation of specific-to-nonspecific fluorine-18-dopa uptake in brain.
    Doudet DJ; McLellan CA; Aigner TG; Wyatt RJ; Cohen RM
    J Nucl Med; 1992 Jul; 33(7):1383-9. PubMed ID: 1613582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nigrofrontal dopaminergic function as assessed by 18F-dopa PET.
    Otsuka M; Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Fukumura T; Masuda K
    Nucl Med Commun; 1995 Dec; 16(12):1021-5. PubMed ID: 8719983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ¹⁸F-DOPA PET/computed tomography imaging.
    Chondrogiannis S; Marzola MC; Rubello D
    PET Clin; 2014 Jul; 9(3):307-21. PubMed ID: 25030394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of carbidopa on the metabolism of 6-[18F]fluoro-L-dopa in rats, monkeys and humans.
    Melega WP; Hoffman JM; Luxen A; Nissenson CH; Phelps ME; Barrio JR
    Life Sci; 1990; 47(2):149-57. PubMed ID: 2117691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.
    Endres CJ; DeJesus OT; Uno H; Doudet DJ; Nickles JR; Holden JE
    Front Biosci; 2004 Jan; 9():505-12. PubMed ID: 14766386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.
    Barrio JR; Huang SC; Melega WP; Yu DC; Hoffman JM; Schneider JS; Satyamurthy N; Mazziotta JC; Phelps ME
    J Neurosci Res; 1990 Dec; 27(4):487-93. PubMed ID: 2127807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
    Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
    J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
    Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
    Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and preliminary evaluation of [18F]FEtP4A, a promising PET tracer for mapping acetylcholinesterase in vivo.
    Zhang MR; Tsuchiyama A; Haradahira T; Furutsuka K; Yoshida Y; Kida T; Noguchi J; Irie T; Suzuki K
    Nucl Med Biol; 2002 May; 29(4):463-8. PubMed ID: 12031881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined FDOPA and 3OMFD PET studies in Parkinson's disease.
    Dhawan V; Ishikawa T; Patlak C; Chaly T; Robeson W; Belakhlef A; Margouleff C; Mandel F; Eidelberg D
    J Nucl Med; 1996 Feb; 37(2):209-16. PubMed ID: 8667046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.
    Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Robotic synthesis of 6-[18F]fluoro-L-dopa.
    Chang CW; Wang HE; Lin HM; Chtsai CS; Chen JB; Liu RS
    Nucl Med Commun; 2000 Sep; 21(9):799-802. PubMed ID: 11065151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats.
    Ishida Y; Kawai K; Magata Y; Abe H; Yoshimoto M; Takeda R; Hashiguchi H; Mukai T; Saji H
    Neurosci Lett; 2005 Nov; 389(1):30-4. PubMed ID: 16043286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.